Abstract
Mouse models have been instrumental for understanding mechanisms of transplant rejection and tolerance, but cross-study reproducibility and translation of experimental findings into effective clinical therapies are issues of concern. The MOuse MOdels in Transplantation (MOMOT) symposium gathered scientists and physician-scientists involved in basic and clinical research in transplantation to discuss the strengths and limitations of mouse transplant models and strategies to enhance their utility. Participants recognized that increased procedure standardization, and including use of prespecified, defined endpoints and statistical power analyses, would benefit the field. They also discussed the generation of new models that incorporate environmental and genetic variables affecting clinical outcomes as potentially important. If implemented, these strategies are expected to improve the reproducibility of mouse studies and increase their translation to clinical trials and, ideally, new FDA-approved drugs.
Original language | English (US) |
---|---|
Journal | American Journal of Transplantation |
DOIs | |
State | E-pub ahead of print - Jan 12 2024 |